Cellular Technologies in Traumatology: From Cells to Tissue Engineering

Injuries and degenerative changes of tendons are common damages of the musculoskeletal system. Due to its hypovascular character the tendon has a limited natural ability to recover. For typical surgical treatment, the tendon integrity is restored, but in most cases, there occurs formation of the connective tissue scar resulting in structural and mechanical functionality disruption. The insufficient effectiveness of traditional therapy methods requires the search for alternative ways to restore damaged tendon tissues. This article discusses new effective methods for improving the treatment that base on the use of cellular technologies among which one of the main directions is mesenchymal stem cell application. Due to mesenchymal stem cells, there is a shift from pro-fibrotic and pro-inflammatory reactions of cells to pro-regenerative ones. Stem cells being multipotent and having among other things tenogenic potential are considered a promising material for repairing damaged tendons. The article also describes the sources of progenitor tendon cells including the tendon bundles and pericytes the main markers of which are Scx and Mkx that are proteins of the transcription factor superfamily, and Tnmd that is transmembrane glycoprotein.

The growth factors that not only enhance the proliferative activity of mesenchymal stem cells but also promote in vitro tenogenic genes expression as well as the collagen Itype production what is necessary for tendon formation are considered. Along with growth factors, the morphogenetic protein BMP14 is presented, this protein increases themesenchymal stem cell proliferation and contributes directed tenogenic differentiation of these cells, suppressing their adipogenic and chondrogenic potentials.

In recent years, mesenchymal stem cells have been used both separately and in combination with various growth factors and different three-dimensional structures providing the interaction with all of the cell types.

The issues of the latest 3D-bioprinting technology allowing to make tissue-like structures for replacement damaged tissues and organs are discussed. 3D-bioprinting technology is known to allow acting exact spatio-temporal control of the distribution of cells, growth factors, small molecules, drugs and biologically active substances. 

1. Walia B, Huang AH. Tendon stem progenitor cells: Understanding the biology to inform therapeutic strategies for tendon repair. JOrthop Res. 2019; 37(6): 1270-1280. doi: 10.1002/jor.24156

2. Andarawis-Puri N, Flatow EL, Soslowsky LJ. Tendon basic science: Development, repair, regeneration, and healing. JOrthop Res. 2015; 33(6): 780-784. doi: 10.1002/jor.22869

3. Schneider M, Angele P, Järvinen TAH, Docheva D. Rescue plan for Achilles: Therapeutics steering the fate and functions of stem cells in tendon wound healing. Adv Drug Deliv Rev. 2018; 129: 352-375. doi: 10.1016/j.addr.2017.12.016

4. Ponomarenko NS, Kuklin IA, Monastyrev VV, Mihajlov IN, Rudakov AN, Bubnov AS, et al. Comparison of the results of surgical treatment of patients with calcaneal tendon injury in Myerson grade II and III diastasis using the plantar muscle tendon. Acta biomedica scientifica. 2018; 3(3): 170-175. doi: 10.29413/ABS.2018- 3.3.32. (In Russ.)

5. D’Addona A, Maffulli N, Formisano S, Rosa D. Inflammation in tendinopathy. Surgeon. 2017; 15(5): 297-302. doi: 10.1016/j.surge.2017.04.004

6. Ackerman JE, Studentsova V, Myers M, Buckley MR, Richards MS, Loiselle AE. Non-invasive ultrasound quantification of scar tissue volume identifies early functional changes during tendon healing. JOrthop Res. 2019; 37(11): 2476-2485. doi: 10.1002/jor.24397

7. Howell K, Chien C, Bell R, Laudier D, Tufa SF, Keene DR, et al. Novel model of tendon regeneration reveals distinct cell mechanisms underlying regenerative and fibrotic tendon healing. Sci Rep. 2017; 23(7): 45238. doi: 10.1038/srep45238

8. Santos AL, Silva CG, Barretto LSS, Franciozi CES, Tamaoki MJS, Almeida FG, et al. Biomechanical evaluation of tendon regeneration with adipose-derived stem cell. J Orthop Res. 2019; 37(6): 1281-1286. doi: 10.1002/jor.24182

9. Bonnin M, Lustig S, Huten D. Extensor tendon ruptures after total knee arthroplasty. Orthop Traumatol Surg Res. 2016; 102(1): 21-31. doi: 10.1016/j.otsr.2015.06.025

10. Leonova SN, Monastyrev VV, Ponomarenko NS. Using a new approach to arthroscopic autoplasty ofthe anterior cruciate ligament initstraumatic injury. Politravma. 2019; 4: 52-57. (In Russ.)

11. Condello V, Zdanowicz U, Matteo BD, Spalding T, Gelber PE, Adravanti P, et al. Allograft tendons are a safe and effective option for revision ACL reconstruction: A clinical review. Knee Surg Sports Traumatol Arthrosc. 2019; 27(6): 1771-1781. doi: 10.1007/s00167-018-5147-4

12. Gillespie RJ, Knapik DM, Akkus O. Biologic and synthetic grafts in the reconstruction of large to massive rotator cuff tears. J Am Acad Orthop Surg. 2016; 24(12): 823-828. doi: 10.5435/JAAOS-D-15-00229

13. Iannotti JP, Codsi MJ, Kwon YW, Derwin K, Ciccone J, Brems JJ. Porcine small intestine submucosa augmentation of surgical repair of chronic two-tendon rotator cuff tears. A randomized, controlled trial. J Bone Joint Surg Am. 2006; 88(6): 1238-1244. doi: 10.2106/JBJS.E.00524

14. Gupta AK, Hug K, Berkoff DJ, Boggess BR, Gavigan M, Malley PC, et al. Dermal tissue allograft for the repair of massive irreparable rotator cuff tears. Am J Sports Med. 2012; 40(1): 141-147. doi: 10.1177/0363546511422795

15. Smith PA, Stannard JP, Bozynski CC, Kuroki K, Cook CR, Cook JL. Patellar bone-tendon-bone autografts versus quadriceps tendon allograft with synthetic augmentation in a canine model. J Knee Surg. 2020; 33(12): 1256-1266. doi: 10.1055/s-0039-1695040

16. Galatz LM, Gerstenfeld L, Heber-Katz E, Rodeo SA. Tendon regeneration and scar formation: The concept of scarless healing. J Orthop Res. 2015; 33(6): 823-831. doi: 10.1002/jor.22853

17. Thaunat M, Fayard JM, Sonnery-Cottet B. Hamstring tendons or bone-patellar tendon-bone graft for anterior cruciate ligament reconstruction? Orthop Traumatol Surg Res. 2019; 105(1): 89-94. doi: 10.1016/j.otsr.2018.05.014

18. Samora JB, Klinefelter RD. Flexor tendon reconstruction. J Am Acad Orthop Surg. 2016; 24(1): 28-36. doi: 10.5435/jaaos-d-14-00195

19. Shurygina IА, Shurygin МG, Ayushinova NI, Каnya ОV. Fibroblasts and their role in connective tissue development. Sibirskij medicinskij zhurnal. 2012; 110(3): 8-12. (In Russ.)

20. Atala A, Irvine DJ, Moses M, Shaunak S. Wound healing versus regeneration: Role of the tissue environment in regenerative medicine. MRS Bull. 2010; 35(8): 10.1557/mrs2010.528. doi: 10.1557/mrs2010.528

21. MacLean S, Khan WS, Malik AA, Snow M, Anand S. Tendon regeneration and repair with stem cells. Stem Cells Int. 2012; 2012: 316281. doi: 10.1155/2012/316281

22. Dremina NN, Trukhan IS, Shurygina IА. Cellular technologies in traumatology: From the cell to cellular engineering. Acta biomedica scientifica. 2020; 5(6): 66-76. doi: 10.29413/ABS.2020-5.6.8. (In Russ.)

23. Costa-Almeida R, Calejo I, Gomes ME. Mesenchymal stem cells empowering tendon regenerative therapies. Int J Mol Sci. 2019; 20(12): 3002. doi: 10.3390/ijms20123002

24. Calve S, Dennis RG, Kosnik PE, Baar K, Grosh K, Arruda EM. Engineering of functional tendon. Tissue Eng. 2004; 10(5-6): 755- 761. doi: 10.1089/1076327041348464

25. Dyment NA, Hagiwara Y, Matthews BG, Li Y, Kalajzic I, Rowe DW. Lineage tracing of resident tendon progenitor cells during growth and natural healing. PLoS One. 2014; 9(4): 96113. doi: 10.1371/journal.pone.0096113

26. Docheva D, Hunziker EB, Fässler R, Brandau O. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol. 2005; 25(2): 699-705. doi: 10.1128/MCB.25.2.699-705.2005

27. Liu W, Watson SS, Lan Y, Keene DR, Ovitt CE, Liu H, et al. The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. Mol Cell Biol. 2010; 30(20): 4797-4807. doi: 10.1128/MCB.00207-10

28. Lejard V, Blais F, Guerquin MJ, Bonnet A, Bonnin MA, Havis E, et al. EGR1 and EGR2 involvement in vertebrate tendon differentiation. J Biol Chem. 2011; 286(7): 5855-5867. doi: 10.1074/jbc.M110.153106

29. Mienaltowski MJ, Adams SM, Birk DE. Regional differences in stem cell/progenitor cell populations from the mouse achilles tendon. Tissue Eng Part A. 2013; 19(1-2): 199-210. doi: 10.1089/ten.TEA.2012.0182

30. Yao L, Bestwick CS, Bestwick LA, Maffulli N, Aspden RM. Phenotypic drift in human tenocyte culture. Tissue Eng. 2006; 12(7): 1843-1849. doi: 10.1089/ten.2006.12.1843

31. Lavrentieva A, Majore I, Kasper C, Hass R. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal. 2010; 8: 18. doi: 10.1186/1478-811X-8-18

32. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: A review. Curr Rev Musculoskelet Med. 2008; 1(3-4): 165-174. doi: 10.1007/s12178-008-9032-5

33. Shurygin МG, Shurygina IА, Dremina NN. Effect of vascular endothelial growth factor on the level of collagen formation in the course of postinfarction cardiosclerosis. Sibirskij medicinskij zhurnal (Irkutsk). 2008; 78(3): 53-55. (In Russ.)

34. Dremina NN, Surygina IА, Lushnikova ЕL, Nepomnyashchih LМ. Effect of endothelial growth factor on postinfarction modeling of rat myocardium. Byulleten’ eksperimental’noj biologii i mediciny. 2009; 148(9): 330-336. (In Russ.)

35. Caliari SR, Harley BAC. Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds. Tissue Eng Part A. 2013; 19(9-10): 1100- 1112. doi: 10.1089/ten.TEA.2012.0497

36. Pryce BA, Watson SS, Murchison ND, Staverosky JA, Dünker N, Schweitzer R. Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation. Development. 2009; 136(8): 1351-1361. doi: 10.1242/dev.027342

37. Oh JH, Chung SW, Kim SH, Chung JY, Kim JY.Neer Award: Effect of the adipose-derived stem cell for the improvement of fatty degeneration and rotator cuff healing in rabbit model. J Shoulder Elbow Surg. 2014; 23(4): 445-455. doi: 10.1016/j.jse.2013.07.054

38. Al-Ani MK, Xu K, Sun Y, Pan L, Xu Z, Yang L. Study of bone marrow mesenchymal and tendon-derived stem cells transplantation on the regenerating effect of Achilles tendon ruptures in rats. Stem Cells Int. 2015; 2015: 984146. doi: 10.1155/2015/984146

39. Ni M, Rui YF, Tan Q, Liu Y, Xu LL, Chan KM, et al. Engineered scaffold-free tendon tissue produced by tendon-derived stem cells. Biomaterials. 2013; 34(8): 2024-2037. doi: 10.1016/j.biomaterials.2012.11.046

40. Augustyniak J, Bertero A, Coccini T, Baderna D, Buzanska L, Caloni F. Organoids are promising tools for species-specific in vitro toxicological studies. JAppl Toxicol. 2019; 39(12): 1610-1622. doi: 10.1002/jat.3815

41. Diaz-Rodriguez P, Erndt-Marino J, Chen H, Diaz-Quiroz JF, Samavedi S, Hahn MS. Abioengineered invitro osteoarthritis model withtunable inflammatory environments indicates context-dependent therapeutic potential of human mesenchymal stem cells. Regenerative Engineering and Translational Medicine. 2019; 5: 297-307.

42. Loh QL, Choong C. Three-dimensional scaffolds for tissue engineering applications: Role of porosity and pore size. Tissue Eng Part B Rev. 2013; 19(6): 485-502. doi: 10.1089/ten.TEB.2012.0437

43. Volkova IМ, Korovina DG. Three-dimensional matrices of natural and synthetic origin for cell biotechnology. Biotekhnologiya. 2015; 31(2): 8-26. (In Russ.)

44. Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016; 51(1): 8-12. doi: 10.1016/j.jpedsurg.2015.10.022

45. Zhang K, Fan Y, Dunne N, Li X. Effect of microporosity on scaffolds for bone tissue engineering. Regen Biomater. 2018; 5(2): 115-124. doi: 10.1093/rb/rby001

46. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl JMed. 2001; 344(5): 385-386. doi: 10.1056/NEJM200102013440516

47. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R. Stem cells associated with macroporous bioceramics forlong bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng. 2007; 13(5): 947-955. doi: 10.1089/ten.2006.0271

48. Zhang C, Zhang E, Yang L, Tu W, Lin J, Yuan C, et al. Histone deacetylase inhibitor treated cell sheet from mouse tendon stem/ progenitor cells promotes tendon repair. Biomaterials. 2018; 172: 66-82. doi: 10.1016/j.biomaterials.2018.03.043

49. Rinoldi C, Fallahi A, Yazdi IK, Paras JC, Kijeńska-Gawrońska E, Santiago GT, et al. Mechanical and biochemical stimulation of 3D multilayered scaffolds for tendon tissue engineering. ACS Biomater Sci Eng. 2019; 5(6): 2953-2964. doi: 10.1021/acsbiomaterials.8b01647

50. Xing F, Xiang Z, Rommens PM, Ritz U. 3D bioprinting for vascularized tissue-engineered bone fabrication. Materials (Basel). 2020; 13(10): 2278. doi: 10.3390/ma13102278

51. Zhang YS, Oklu R, Dokmeci MR, Khademhosseini A. Three-dimensional bioprinting strategies for tissue engineering. Cold Spring Harb Perspect Med. 2018; 8(2): 025718. doi: 10.1101/ cshperspect.a025718

52. Tarafder S, Brito JA, Minhas S, Effiong L, Thomopoulos S, Lee CH. In situ tissue engineering of the tendon-to-bone interface by endogenous stem/progenitor cells. Biofabrication. 2019; 12(1): 015008. doi: 10.1088/1758-5090/ab48ca

53. Marques CF, Diogo GS, Pina S, Oliveira JM, Silva TH, Reis RL. Collagen-based bioinks for hard tissue engineering applications: A comprehensive review. J Mater Sci Mater Med. 2019; 30(3): 32. doi: 10.1007/s10856-019-6234-x

54. Li J, Chen M, Fan X, Zhou H. Recent advances in bioprinting techniques: Approaches, applications and future prospects. J Transl Med. 2016; 14: 271. doi: 10.1186/s12967-016-1028-0

55. Xu C, Chai W, Huang Y, Markwald RR. Scaffold-free inkjet printing of three-dimensional zigzag cellular tubes. Biotechnol Bioeng. 2012; 109(12): 3152-3160. doi: 10.1002/bit.24591

56. Lee VK, Lanzi AM, Haygan N, Yoo SS, Vincent PA, Dai G. Generation of multi-scale vascular network system within 3D hydrogel using 3D bio-printing technology. Cell Mol Bioeng. 2014; 7(3): 460-472. doi: 10.1007/s12195-014-0340-0

57. Keriquel V, Guillemot F, Arnault I, Guillotin B, Miraux S, Amédée J, et al. In vivo bioprinting for computer- and robotic-assisted medical intervention: Preliminary study in mice. Biofabrication. 2010; 2(1): 014101. doi: 10.1088/1758-5082/2/1/014101

58. Boyette LB, Creasey OA, Guzik L, Lozito T, Tuan RS. Human bone marrow-derived mesenchymal stem cells display enhanced clonogenicity but impaired differentiation with hypoxic preconditioning. Stem Cells Transl Med. 2014; 3(2): 241-254. doi: 10.5966/sctm.2013-0079

59. Norotte C, Marga FS, Niklason LE, Forgacs G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials. 2009; 30(30): 5910-5917. doi: 10.1016/j.biomaterials. 2009.06.034

60. Matai I, Kaur G, Seyedsalehi A, McClinton A, Laurencin CT. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials. 2020; 226: 119536. doi: 10.1016/j. biomaterials.2019.119536

61. Snedeker JG, Foolen J. Tendon injury and repair – A perspective on the basic mechanisms of tendon disease and future clinical therapy. Acta Biomater. 2017; 63: 18-36. doi: 10.1016/j.actbio.2017.08.032

62. Leong NL, Kator JL, Clemens TL, James A, Enamoto-Iwamoto M, Jiang J. Tendon and ligament healing and current approaches to tendon and ligament regeneration. J Orthop Res. 2020; 38(1): 7-12. doi: 10.1002/jor.24475

63. Lui PP. Identity of tendon stem cells – how much do we know? J Cell Mol Med. 2013; 17(1): 55-64. doi: 10.1111/jcmm.12007

64. Qu SW, Xue YN, Li P, Zhou JD. Advances in the research of stem cell tissue-engineering. Zhonghua Shao Shang Za Zhi. 2020; 36(6): 510-515. doi: 10.3760/cma.j.cn501120-20190225-00039